2019-06 TRISCEND Study
Edwards EVOQUE Tricuspid Valve Replacement: Investigation of Safety and Clinical Efficacy After Replacement of Tricuspid Valve With Transcatheter Device
Sponsor: Edwards Lifesciences
A NA clinical study on Cardiovascular Diseases and Heart Valve Diseases, this trial is ongoing. The trial is conducted by Edwards Lifesciences and has accumulated 22 data snapshots since 2020. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
22 versions recorded-
Feb 2026 — Present [monthly]
Active Not Recruiting NA
-
Sep 2025 — Feb 2026 [monthly]
Active Not Recruiting NA
-
Mar 2025 — Sep 2025 [monthly]
Active Not Recruiting NA
-
Feb 2025 — Mar 2025 [monthly]
Active Not Recruiting NA
-
Sep 2024 — Feb 2025 [monthly]
Active Not Recruiting NA
▶ Show 17 earlier versions
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
May 2024 — Jul 2024 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Feb 2024 — May 2024 [monthly]
Recruiting NA
-
Dec 2023 — Feb 2024 [monthly]
Recruiting NA
-
Aug 2023 — Dec 2023 [monthly]
Recruiting NA
-
Sep 2022 — Aug 2023 [monthly]
Recruiting NA
-
Mar 2022 — Sep 2022 [monthly]
Recruiting NA
-
Sep 2021 — Mar 2022 [monthly]
Recruiting NA
-
Apr 2021 — Sep 2021 [monthly]
Recruiting NA
-
Jan 2021 — Apr 2021 [monthly]
Recruiting NA
-
Dec 2020 — Jan 2021 [monthly]
Recruiting NA
-
Nov 2020 — Dec 2020 [monthly]
Recruiting NA
-
Oct 2020 — Nov 2020 [monthly]
Recruiting NA
-
Sep 2020 — Oct 2020 [monthly]
Recruiting NA
-
Aug 2020 — Sep 2020 [monthly]
Recruiting NA
-
Jul 2020 — Aug 2020 [monthly]
Recruiting NA
Status: Withheld → Recruiting · Phase: None → NA
-
Feb 2020 — Jul 2020 [monthly]
Withheld
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Edwards Lifesciences
For direct contact, visit the study record on ClinicalTrials.gov .